Back to search

Article

Prevalent Landscape of Tumor Genomic Alterations of Luminal B1 Breast Cancers Using a Comprehensive Genomic Profiling Assay in Taiwan

2023-08-17

Abstract excerpt

<title>Abstract</title> <p>Background: The human epidermal growth factor receptor 2 (HER2) negative luminal B1 subtype of breast cancer has been reported with a poorer outcome than luminal A in recent studies. This study aimed to investigate the molecular alterations and identify potential therapeutic targets by analyzing the genetic profiling from a cohort of luminal B1 breast cancer in Taiwan. <h4>Methods:</h4...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9b2c92df-290e-5903-b248-fc75f04ba4c2
DOI
10.21203/rs.3.rs-3240209/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prevalent Landscape of Tumor Genomic Alterations of Luminal B1 Breast Cancers Using a Comprehensive Genomic Profiling Assay in TaiwanDOI 10.21203/rs.3.rs-3240209/v1
Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in Taiwan.Semantic proximity
Comprehensive Genomic Profiling of Taiwanese Breast Cancer Using a Novel Targeted Sequencing PanelSemantic proximity
Comprehensive genomic profiling of Taiwanese triple-negative breast cancer with a large targeted sequencing panel.Semantic proximity
Comprehensive molecular profiling of Taiwanese breast cancers revealed potential therapeutic targets: prevalence of actionable mutations among 380 targeted sequencing analysesSemantic proximity
Comprehensive molecular profiling of Taiwanese breast cancers revealed potential therapeutic targets: prevalence of actionable mutations among 380 targeted sequencing analyses.Semantic proximity
Comprehensive genomic profiling of Taiwanese triple negative breast cancers with medium- and large-sized sequencing panels: a comparative study of actionable genesSemantic proximity
Clinical Genomic Profiling to Identify Actionable Alterations for Very Early Relapsed Triple-Negative Breast Cancer Patients in the Chinese PopulationSemantic proximity
Comprehensive genomic profiling and therapeutic implications for Taiwanese patients with treatment-naïve breast cancer.Semantic proximity
Research on the pathological features of BRCA-mutated breast cancer in Shenzhen, China: A single-center studySemantic proximity
Genomic alterations in breast cancer: level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)Semantic proximity
Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population.Semantic proximity
Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population.Semantic proximity
Select a neighboring publication to make it the new centre.